- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Latest Conference Articles
.jpg?w=350&fit=crop&auto=format)
DIPRA: Distal Radial Access Safe, No Negative Impact on Hand Function vs Proximal Radial Access
May 23rd 2022
Society for Cardiovascular Angiography and Interventions
Data from an interim analysis of the DIPRA trial suggest distal radial artery access for cardiac catheterization and resulted in no significant differences in hand function compared to proximal radial artery access.
SAFE-PAD: No Difference in Mortality with Paclitaxel-Coated Devices Up to 6 Years Out
May 21st 2022
Society for Cardiovascular Angiography and Interventions
Long-term data from the SAFE-PAD trial at SCAI 2022 underlines the noninferiority of paclitaxel-coated devices versus non-drug-coat devices for use in patients with peripheral artery disease.
Clopidogrel Tops Aspirin for Long-Term Antiplatelet Therapy After PCI in High-Risk Patients
May 20th 2022
Society for Cardiovascular Angiography and Interventions
An analysis of data from the Fuwai PCI registry details the incidence of adverse events and risk of bleeding associated with clopidogrel monotherapy versus aspirin monotherapy 12 months post-PCI in high-risk patients.
.jpg?w=350&fit=crop&auto=format)
Q&A on SCAI's 2022 PFO Guidelines, with Clifford Kavinsky, MD, PhD
May 20th 2022
Society for Cardiovascular Angiography and Interventions
Chair of the SCAI's writing group for their 2022 guidelines on management of patent foramen ovale, Dr. Clifford Kavinsky, sits down with Practical Cardiology to take part in a Q&A on the guideline's recommendations and the writing process for the SCAI's first PFO guidance.
.jpg?w=350&fit=crop&auto=format)
Phase 2b Trial of Bentracimab Supports Use in Older Patients
April 6th 2022
American College of Cardiology
Data from a phase 2b trial of bentracimab presented by Deepak Bhatt, MD, MPH, at ACC.22 demonstrates it the ability for reversing antiplatelet effects in an older population.
Don't Miss a Beat: ACC.22 Recap of DIAMOND, SODIUM-HF, and PROMPT-HF
April 5th 2022
American College of Cardiology
Don't Miss a Beat hosts Drs. Vaduganathan and Greene provide insight into the results of trials from ACC.22 late-breaking sessions they highlighted in the preview episode they recorded ahead of the American College of Cardiology's 71st Annual Scientific Session.
%20(1).jpg?w=350&fit=crop&auto=format)
Patiromer Use Could Help Heart Failure Patients Stay on Optimized RAASi Therapy
April 4th 2022
American College of Cardiology
Data from the DIAMOND trial suggests use of patiromer could help patients maintain optimized RAASi therapy, even if they were experiencing or had a history of hyperkalemia.
Sotagliflozin Reduces Stroke, MI, and CV Death, Regardless of CVD History
April 4th 2022
American College of Cardiology
Deepak Bhatt, MD, MPH, breaks down data from the SCORED trial presented at ACC.22, which demonstrated sotagliflozin provided significant benefit in terms of reducing total MACE, total MI, and total stroke, regardless of whether a patient had a history of cardiovascular disease.
.jpg?w=350&fit=crop&auto=format)
TAVR Associated with Lower Risk of Valve Deterioration than SAVR
April 4th 2022
American College of Cardiology
A large-scale analysis of data from a pair of RCTs and a nonrandomized registry provide insight into the risk of valve deterioration seen with TAVR vs SAVR and to what extent this might influence risk of mortality.